Clinical Trial

Improving Glycemic Control With Telemedicine and Smart Insulin Pens

Recruiting
View on ClinicalTrials.gov →
Summary
Almost 40% of veterans have diabetes, the proposed research may improve clinical care among veterans with diabetes. In this application we are going to examine whether utilizing Smart Insulin pens (SIPs) with CGMs and telemedicine is a better tool for managing diabetes compared to traditional insulin pens, CGMs and telemedicine, leading to improved blood sugar control and better clinical outcomes.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-02; most recent amendment 2026-02-06.
Status change: Not Yet Recruiting → Recruiting 2026-02-06
Trial Details
NCT Number NCT06918977
Lead Sponsor University of Maryland, Baltimore
Collaborators: Medtronic
Conditions Diabetes Mellitus
Enrollment 50 participants
Start Date 2026-01-30
Primary Completion 2028-05-30 (estimated)
Study Completion 2028-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-10